6533b835fe1ef96bd129f593
RESEARCH PRODUCT
Management of severe asthma during the first lockdown phase of SARS-CoV-2 pandemic: Tips for facing the second wave.
Benfante AlidaPrincipe StefaniaSeminara GabrieleCicero Maria NoemiIncandela MariaScichilone NicolaDurante Carmensubject
Pulmonary and Respiratory MedicineCOVID-19 Health-care management Respiratory symptoms Severe asthmasevere asthmamedicine.medical_specialtyTelemedicineCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaSettore MED/10 - Malattie Dell'Apparato RespiratorioPhase (combat)ArticlePandemicmedicineAsthmatic patientHumansPharmacology (medical)Intensive care medicinehealth-care managementPandemicsbusiness.industrySARS-CoV-2Biochemistry (medical)Patient contactrespiratory symptomsCOVID-19AsthmaCommunicable Disease Controlbusinessdescription
SARS-CoV-2 pandemic has contributed to implement telemedicine, allowing clinicians to follow the patient remotely, therefore minimizing the risk of any exposure to positive COVID-19 patients. We summarize the approaches adopted to treat and monitor severe asthmatic patients during the lockdown phase of the pandemic. Our experience supports the strategy that every effort should be made to minimize patient contact with the health-care system, planning a pathway that allows patients to receive appropriate medical care and continue the biological therapies, thus preventing the loss of disease control and acute severe exacerbations.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2022-06-01 | Pulmonary pharmacologytherapeutics |